Logo image of IPI

INTREPID POTASH INC (IPI) Stock Fundamental Analysis

NYSE:IPI - New York Stock Exchange, Inc. - US46121Y2019 - Common Stock

26.51  -0.23 (-0.86%)

After market: 26.51 0 (0%)

Fundamental Rating

3

Taking everything into account, IPI scores 3 out of 10 in our fundamental rating. IPI was compared to 85 industry peers in the Chemicals industry. IPI has a great financial health rating, but its profitability evaluates not so good. IPI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year IPI has reported negative net income.
In the past year IPI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: IPI reported negative net income in multiple years.
In the past 5 years IPI always reported a positive cash flow from operatings.
IPI Yearly Net Income VS EBIT VS OCF VS FCFIPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

IPI has a worse Return On Assets (-5.34%) than 77.11% of its industry peers.
IPI's Return On Equity of -6.33% is on the low side compared to the rest of the industry. IPI is outperformed by 69.88% of its industry peers.
Industry RankSector Rank
ROA -5.34%
ROE -6.33%
ROIC N/A
ROA(3y)12.34%
ROA(5y)6.89%
ROE(3y)14.18%
ROE(5y)7.81%
ROIC(3y)N/A
ROIC(5y)N/A
IPI Yearly ROA, ROE, ROICIPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100

1.3 Margins

In the last couple of years the Operating Margin of IPI has declined.
Looking at the Gross Margin, with a value of 10.33%, IPI is doing worse than 84.34% of the companies in the same industry.
In the last couple of years the Gross Margin of IPI has declined.
IPI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.33%
OM growth 3YN/A
OM growth 5Y-64.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y35.3%
GM growth 5Y-6.41%
IPI Yearly Profit, Operating, Gross MarginsIPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

7

2. Health

2.1 Basic Checks

IPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IPI has more shares outstanding
Compared to 5 years ago, IPI has less shares outstanding
IPI has a worse debt/assets ratio than last year.
IPI Yearly Shares OutstandingIPI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
IPI Yearly Total Debt VS Total AssetsIPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.23 indicates that IPI is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of IPI (2.23) is better than 62.65% of its industry peers.
The Debt to FCF ratio of IPI is 0.07, which is an excellent value as it means it would take IPI, only 0.07 years of fcf income to pay off all of its debts.
IPI has a better Debt to FCF ratio (0.07) than 98.80% of its industry peers.
IPI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
IPI has a better Debt to Equity ratio (0.00) than 96.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 2.23
ROIC/WACCN/A
WACC9.27%
IPI Yearly LT Debt VS Equity VS FCFIPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 4.41 indicates that IPI has no problem at all paying its short term obligations.
The Current ratio of IPI (4.41) is better than 92.77% of its industry peers.
A Quick Ratio of 1.87 indicates that IPI should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.87, IPI is doing good in the industry, outperforming 71.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.41
Quick Ratio 1.87
IPI Yearly Current Assets VS Current LiabilitesIPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

IPI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -175.00%.
Looking at the last year, IPI shows a very negative growth in Revenue. The Revenue has decreased by -11.60% in the last year.
IPI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.03% yearly.
EPS 1Y (TTM)-175%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.58%
Revenue 1Y (TTM)-11.6%
Revenue growth 3Y12.31%
Revenue growth 5Y6.03%
Sales Q2Q%5.66%

3.2 Future

IPI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -19.45% yearly.
The Revenue is expected to decrease by -3.04% on average over the next years.
EPS Next Y3.21%
EPS Next 2Y12.41%
EPS Next 3Y-19.45%
EPS Next 5YN/A
Revenue Next Year-12.76%
Revenue Next 2Y-5.02%
Revenue Next 3Y-3.04%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IPI Yearly Revenue VS EstimatesIPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
IPI Yearly EPS VS EstimatesIPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IPI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPI Price Earnings VS Forward Price EarningsIPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IPI is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, IPI is valued a bit cheaper than 77.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.47
EV/EBITDA 10.47
IPI Per share dataIPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

IPI's earnings are expected to decrease with -19.45% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.41%
EPS Next 3Y-19.45%

More info and screens

0

5. Dividend

5.1 Amount

IPI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTREPID POTASH INC

NYSE:IPI (1/17/2025, 8:08:30 PM)

After market: 26.51 0 (0%)

26.51

-0.23 (-0.86%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Inst Owners61.52%
Inst Owner Change0.01%
Ins Owners1.29%
Ins Owner Change-1.51%
Market Cap348.87M
Analysts42.22
Price Target19.38 (-26.9%)
Short Float %2.41%
Short Ratio2.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-647.37%
Min EPS beat(2)-1288.12%
Max EPS beat(2)-6.63%
EPS beat(4)0
Avg EPS beat(4)-351.28%
Min EPS beat(4)-1288.12%
Max EPS beat(4)-6.63%
EPS beat(8)0
Avg EPS beat(8)-231.5%
EPS beat(12)1
Avg EPS beat(12)-161.47%
EPS beat(16)4
Avg EPS beat(16)-113.17%
Revenue beat(2)2
Avg Revenue beat(2)24.77%
Min Revenue beat(2)20.59%
Max Revenue beat(2)28.94%
Revenue beat(4)4
Avg Revenue beat(4)25.45%
Min Revenue beat(4)20.59%
Max Revenue beat(4)28.94%
Revenue beat(8)8
Avg Revenue beat(8)26.87%
Revenue beat(12)11
Avg Revenue beat(12)19.53%
Revenue beat(16)15
Avg Revenue beat(16)18.75%
PT rev (1m)0%
PT rev (3m)11.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-135.75%
EPS NY rev (1m)0%
EPS NY rev (3m)24.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)9.96%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.37
P/FCF 11.47
P/OCF 5.02
P/B 0.51
P/tB 0.53
EV/EBITDA 10.47
EPS(TTM)-0.75
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)2.31
FCFY8.72%
OCF(TTM)5.29
OCFY19.94%
SpS19.42
BVpS51.72
TBVpS49.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.34%
ROE -6.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.33%
FCFM 11.9%
ROA(3y)12.34%
ROA(5y)6.89%
ROE(3y)14.18%
ROE(5y)7.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.04%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-64.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y35.3%
GM growth 5Y-6.41%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA 0.07
Cap/Depr 102.8%
Cap/Sales 15.32%
Interest Coverage N/A
Cash Conversion 235.77%
Profit Quality N/A
Current Ratio 4.41
Quick Ratio 1.87
Altman-Z 2.23
F-Score4
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)138.85%
Cap/Depr(5y)139.45%
Cap/Sales(3y)17%
Cap/Sales(5y)19.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-175%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.58%
EPS Next Y3.21%
EPS Next 2Y12.41%
EPS Next 3Y-19.45%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.6%
Revenue growth 3Y12.31%
Revenue growth 5Y6.03%
Sales Q2Q%5.66%
Revenue Next Year-12.76%
Revenue Next 2Y-5.02%
Revenue Next 3Y-3.04%
Revenue Next 5YN/A
EBIT growth 1Y-151.33%
EBIT growth 3YN/A
EBIT growth 5Y-62.85%
EBIT Next Year6210.1%
EBIT Next 3Y289.56%
EBIT Next 5YN/A
FCF growth 1Y-31.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.66%
OCF growth 3Y11.6%
OCF growth 5Y-7.61%